Piper Sandler lowered the firm’s price target on CME Group to $235 from $250 and keeps an Overweight rating on the shares. Despite persistently low volatility, the firm expects the U.S. exchanges to generally report solid Q2 results driven by continued strength in trading volumes across a range of asset classes, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group (NASDAQ:CME): The Next Great Dividend Stock
- CME Group Announces Executive Shift and Board Vacancy
- CME Group reports Q2 international ADV 7.8M contracts
- CME Group reports June ADV of 25.3M contracts, Q2 ADV of 26M contracts
- CME Group, Google Cloud to build new private Google Cloud region in Illinois
